316 results about "Sex organ" patented technology

Systems and methods treat urologic dysfunctions by implanting a lead and electrode in a tissue region affecting urologic function, and implanting a pulse generator in an anterior pelvic region remote from the electrode. Bilateral stimulation of the left and/or right branches of the dorsal genital nerves using a single lead implanted in adipose or other tissue in the region at or near the pubic symphysis is able to treat urinary incontinence.

Systems and methods treat urinary incontinence by the bilateral stimulation of the left and/or right branches of the dorsal genital nerves using a single lead implanted in adipose or other tissue in the region at or near the pubic symphysis.

Therapeutic devices and methods according to embodiments of the invention alleviate e.g. urinary incontinence in female and male patients. Suction or vacuum, for example, is applied to the genital region, clitoris or clitoral region, the external urethral orifice, and/or other designated areas, e.g. physically stimulating the sacral/pudendal nerves and/or nerve roots and alleviating incontinence. Such embodiments also can encourage or cause clitoral engorgement, or otherwise promote blood flow in the genital region. Vacuum or suction applied to e.g. the clitoris creates a negative pressure in the clitoris that is lower than the systolic blood pressure, tending to promote engorgement of the clitoris with blood. Aspects of the invention are applicable not only to treatment of urinary and fecal incontinence, but also to the treatment of female sexual dysfunction. Aspects of the invention are also applicable to treatment of male incontinence and male erectile dysfunction.

A unisex protective garment worn by both male and female animals, particularly dogs, the garment having a first forward harness portion and a rear genitalia protection portion. The rear portion includes a woven vinyl mesh material covering both the male genitalia and the female genitalia, in the same unisex garment, which would allow fluid flow, such as urine therethrough, but would prevent contact between male and female genitalia. This garment, when worn by either a male of female dog, would allow the dog to urinate and defecate, but would not allow the dog to copulate with the opposite sex.

This invention is a probiotic composition using the delivery mode of a rectal suppository for the treatment and relief of symptoms of urogenital infections including prostatitis. This invention is unique in both mode of delivery and in enabling the treatment of such urogenital infections as prostatitis. The present invention discloses compositions, methodologies, and delivery mode for the utilization of probiotic organisms in therapeutic compositions for treatment and relief from the symptoms of urogenital infections by maintaining and restoring normal flora in humans. The composition includes one or more bacteria selected from the genus Lactobacillus. More specifically, the invention relates to the utilization of one or more species or strains of Lactobacillus producing bacteria for the control of urinary tract bacteria and pathogens, including antibiotic-resistant urinary tract pathogens, and their associated diseases by both a reduction in the rate of colonization of the infection and pathogens. The method for treatment and relief from symptoms includes administration via a rectal suppository with a safe and effective amount of the composition. The delivery mode for administering the probiotic is via a rectal suppository. The delivery through the rectum provides an optimum method of transmission of the treatment.

This invention relates to a genital lubricant composition and to the uses thereof. The composition comprises i) fatty acids and/or homeopathic dilutions of plant extracts and ii) a physiologically acceptable carrier. According to a preferred embodiment, the genital lubricant composition comprises about 0.05% to about 0.5% hemp seed oil and a physiologically acceptable carrier so that it forms a lotion, a cream or a gel. The composition according to the invention is particularly useful for use as a vaginal moisturizer, or as a personal lubricant for use prior or during sexual intercourse.

A male genital protection device configured to conform to the shape of the male genital anatomy, which provides the wearer with added comfort and protection.

The present invention provides, in one embodiment, a method of normalizing the timing of sexual response in a mammal comprising the administration of an amount of a central nervous system sexual response initiator in an amount sufficient to produce genital vasodilation but less than the amount required to produce effective vasocongestive arousal. The method is applicable not only to adjusting or normalizing the timing of sexual response in humans, but in the breeding of valuable commercial animals such as horses, cattle, sheep, swine and the like and domesticated pets such as dogs and cats. In an alternative embodiment, the present invention provides a method for the prophylactic treatment of long-term tissue degradation in the genital organs comprising the administration to a mammal of a central nervous system sexual response initiator in an amount sufficient to produce genital vasodilation but less than the amount required to produce effective vasocongestive arousal. The preferred central nervous system sexual response initiator is apomorphine or a pharmaceutically acceptable acid addition salt thereof.

A driving apparatus of a massaging device for sexual organs comprises a pedestal, a driving device fixed detachably on the pedestal, and moving means provided on the driving device, to which a massaging device for sexual organs is attached. The moving means is moved reciprocally linearly, and vertically substantially, and the massaging device is for male sex organs. The moving means is moved reciprocally linearly, and obliquely substantially, and the massaging device is for female sex organs. A motion of lateral direction is added to the moving means so as to move the moving means along an endless loop.

The present invention relates to a pharmaceutical composition which may comprise progestogens, preferably drospirenone, estrogens, preferably ethinylestradiol and 5-methyl-(6S)-tetrahydrofolate, which may be employed as oral contraceptive and moreover prevents disorders caused by folate deficiency in the consumers, in particular cardiovascular disorders and, after conception of the embryo, congenital malformations caused by folate deficiency such as, for example, neural tube defects, ventricular valve defects, urogenital defects, and cleft lip, jaw and palate, without masking the symptoms of vitamin B₁₂ deficiency, and at the same time even in the case of homozygous or heterozygous polymorphism of methylenetetrahydrofolate reductase facilitates unimpaired utilizability of the folate component 5-methyl-(6S)-tetrahydrofolate by the body and thus its biological activity for preventing the abovementioned congenital malformations caused by folate deficiency. In addition, a prolonged protective effect is maintained after discontinuation of the contraceptive.

The desensitizing device contains an electrical stimulation member optionally configured on a support member. The electrical stimulation member contains a control circuit, at least two electrodes, and an electricity supply element. The electricity supply element provides electricity to the control circuit, and the control circuit generates a stimulating current to the electrodes. By configuring a male genital with the support member so that the electrodes are in contact with the penis skin, the stimulating current produced by the control circuit is conducted to the electrodes and provides a low-strength subcutaneous nerve stimulation through the penis skin. The subcutaneous nerve is as such temporarily numbed and desensitized.

The present invention relates to a modular erogenous stimulation system including at least one vibratory device for stimulating the erogenous zones and at least one control module that for controlling the operation of the vibratory device; and to an embodiment of the at least one vibratory apparatus that may be worn by a female for stimulating the internal vaginal erogenous zones, the external clitoral erogenous zones, or both the internal and external clitoral erogenous zones of the female genitalia simultaneously, while allowing sufficient clearance of the vaginal canal to also permit insertion of a penis or other similarly configured and dimensioned implement, such as a dildo or vibrator, when the apparatus is being properly worn by the female to create an interaction between the partners that is pleasurable for all involved.

The present invention relates to an external urinary incontinence treatment a device and a method of deploying an external urinary incontinence treatment device that minimizes the inconvenience of fastening and fixating a urine receiving component to the genital region and to the skin surrounding the urethral orifice of a treated patient. The device comprises: a urine receiving component, a tube, a receiving component supporting element, a tube locking system, a genital region connection component, and a genital region anchoring element. The tube connects and communicates freely with the urine receiving component and is inserted through the receiving component supporting element. The tube also communicates with said tube locking system and is able to move vertically the receiving component supporting element when said tube locking system is deactivated. The tube is fixated in its movement at a desired position along the length of said tube when said tube locking system is activated. The device receiving component supporting element is connected to the genital region connection component and with the tube locking system. The genital region connection component is connected to the genital region anchoring element. In deployment of the device, the genital region anchoring element is reversibly connected to the skin of the genital region of the treated patient, and urine receiving-component is connected to the skin surrounding the urethral orifice of the treated patient when the tube is moved towards the genital region of the patient. The tube is reversibly fixated in place by the tube locking system after urine receiving component is adjusted and fastened to the skin surrounding the urethral orifice of the patient in a urine leak free connection while applying the minimal required pressure, thus, causing the treated patient minimal inconvenience. The tube lucking system can be easily deactivated and reactivated to adjust the connection of the receiving component to the skin surrounding the urethral orifice in accordance to changing body postures of the patient.

Embodiments of the present invention are directed to apparati and associated methods for an easy on-off device to support and provide direct therapeutic cooling relief to the affected genitalia of persons having post-operative pain and swelling.

A urinary absorbent and retention pouch for male incontinence is provided. The urinary absorbent and retention pouch includes an expandable pocket for containing male genitalia and absorbing and retaining urine discharge resulting from male incontinence. The pocket includes a flexible and elastic material for enabling the pocket to stretch. An elastic band defines an opening for providing access into the pocket and provides sufficient tension to sustain the pouch around the male genitalia. The pocket includes an absorbent interior layer for absorbing secreted urine and a liquid-impermeable exterior layer for retaining the urine in the pouch and preventing soiling. A removably attachable flap provides access to the male genitalia while the pouch is worn. A plurality of accordion pleats enables the pocket to expand its shape while in motion. A fastener enables the pocket to be suspended from a waistband for added support.

An isolated sequence or peptide isolated from an E2, E4, E6, E7 early or late coding region of human papillomavirus (HPV) that is soluble in aqueous medium, and characterized by a linkage to another protein sequence or peptide isolated from the E2, E4, E6, E7 early or late coding region of HPV by a spacer sequence, wherein the isolated protein sequence or peptide consists of more than 50% hydrophilic amino acids, and is recognized by a specific antibody of HPV. Also disclosed are isolated protein sequences or peptides from Harvey Ras (H-Ras), Kirsten Ras (K-Ras), and phosphatase and tensin homologue (PTEN) tumor suppressor proteins and Chlamydia trachomatis heat shock protein 60 (CHSP60 groEL1) and methods for detecting or diagnosing cancer or cellular abnormalities.